Noninvasive Urinary Biomarker Panel Predicts Lupus Nephritis Activity, Response Better Than Proteinuria, Research Finds

Rheumatology Advisor (12/3, Persaud) says, “A noninvasive urinary biomarker panel predicts lupus nephritis activity and response better than proteinuria, and, if further validated, may aid diagnosis and gauge treatment response, investigators reported.” The researchers said, “An improvement in the biomarker panel at 3 months predicted a clinical response at 1 year.” The findings were presented at ACR Convergence 2024.